Document Detail


Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
MedLine Citation:
PMID:  19200137     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Interferon (IFN)-based combination therapy with ribavirin has become the gold standard for the treatment of chronic hepatitis C virus infection. Haematologic toxicities, such as neutropenia, thrombocytopenia, and anaemia, however, frequently cause poor treatment tolerance, resulting in poor therapeutic efficacy. The aim of this study was to identify host genetic polymorphisms associated with the efficacy or haematologic toxicity of IFN-based combination therapy in chronic hepatitis C patients. We performed comprehensive single nucleotide polymorphism detection in all exonic regions of the 12 genes involved in the IFN signalling pathway in 32 healthy Japanese volunteers. Of 167 identified polymorphisms, 35 were genotyped and tested for an association with the efficacy or toxicity of IFN plus ribavirin therapy in 240 chronic hepatitis C patients. Multiple logistic regression analysis revealed that low viral load, viral genotypes 2 and 3, and a lower degree of liver fibrosis, but none of the genetic polymorphisms, were significantly associated with a sustained virologic response. In contrast to efficacy, multiple linear regression analyses demonstrated that two polymorphisms (IFNAR1 10848-A/G and STAT2 4757-G/T) were significantly associated with IFN-induced neutropenia (P = 0.013 and P = 0.011, respectively). Thrombocytopenia was associated with the IRF7 789-G/A (P = 0.031). In conclusion, genetic polymorphisms in IFN signalling pathway-related genes were associated with IFN-induced neutropenia and thrombocytopenia in chronic hepatitis C patients. In contrast to toxicity, the efficacy of IFN-based therapy was largely dependent on viral factors and degree of liver fibrosis.
Authors:
M Wada; H Marusawa; R Yamada; A Nasu; Y Osaki; M Kudo; M Nabeshima; Y Fukuda; T Chiba; F Matsuda
Related Documents :
24901497 - Evolution of amoxicillin resistance of helicobacter pylori in vitro: characterization o...
20369037 - The relationship between the polymorphism of sg13s114 a/t in alox5ap gene and the vulne...
20192597 - Influence of matrix metalloproteinase gene polymorphisms in healthy north indians compa...
20572897 - Il-1 receptor antagonist gene polymorphism in idiopathic recurrent spontaneous abortion...
10077727 - Analysis of the complete coding region of the cftr gene in ten algerian cystic fibrosis...
23322777 - Mechanisms by which von willebrand disease mutations destabilize the a2 domain.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-02-05
Journal Detail:
Title:  Journal of viral hepatitis     Volume:  16     ISSN:  1365-2893     ISO Abbreviation:  J. Viral Hepat.     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-22     Completed Date:  2009-07-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435672     Medline TA:  J Viral Hepat     Country:  England    
Other Details:
Languages:  eng     Pagination:  388-96     Citation Subset:  IM    
Affiliation:
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Female
Genotype
Hepatitis C, Chronic / drug therapy*
Humans
Interferon Regulatory Factor-7 / genetics
Interferons / adverse effects*,  therapeutic use*
Japan
Male
Middle Aged
Neutropenia / chemically induced
Point Mutation
Polymorphism, Genetic*
RNA, Viral / genetics
Receptor, Interferon alpha-beta / genetics
STAT2 Transcription Factor / genetics
Thrombocytopenia / chemically induced
Treatment Outcome
Young Adult
Chemical
Reg. No./Substance:
0/IFNAR1 protein, human; 0/IRF7 protein, human; 0/Interferon Regulatory Factor-7; 0/RNA, Viral; 0/STAT2 Transcription Factor; 0/STAT2 protein, human; 156986-95-7/Receptor, Interferon alpha-beta; 9008-11-1/Interferons

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-cont...
Next Document:  Dispersal in Mastomys natalensis mice: use of fine-scale genetic analyses for pest management.